The role of colony morphotype in shaping gene essentiality in <i>Mycobacteroides abscessus</i>

B Brittany N. Ross (Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology) E Emma Evans (Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology) F Frances Diggle (Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology) P Paul Briaud (Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology) M Marvin Whiteley (Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology)

Abstract

Changes in bacterial colony morphology are common during chronic human infections and are thought to provide a survival advantage. In the human pathogen Mycobacteroides abscessus (MAB), a unidirectional transition from a smooth (MAB S ) to rough (MAB R ) morphotype frequently occurs during chronic infection. This transition has profound clinical implications, as MAB R induces a heightened proinflammatory response, contributing to increased morbidity. To better understand this phenomenon, we used transposon insertion site sequencing (Tn-seq) to identify genes essential for the survival of MAB S and MAB R . Our analysis revealed distinct genetic requirements for growth in vitro, including several genes involved in responding to environmental stresses. Notably, some of these uniquely essential genes are therapeutic targets in mycobacteria. In a murine infection model, the divergence in essential gene profiles between MAB S and MAB R was even more pronounced, driven partly by the differing host immune responses elicited by each morphotype. These findings demonstrate that the transition from a smooth to rough morphotype not only impacts MAB’s survival strategies but also highlights the importance of considering morphotype-specific genetic and functional adaptations when developing therapeutic approaches. Our work underscores the critical need to incorporate morphotype conversion into the prioritization of drug targets, as targeting morphotype-specific vulnerabilities could improve treatment outcomes for infections caused by this pathogen.

Article Details

Volume / Issue Vol. 122, Issue 40
Published October 07, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (5)

B

Brittany N. Ross

Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology

E

Emma Evans

Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology

F

Frances Diggle

Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology

P

Paul Briaud

Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology

M

Marvin Whiteley

Center for Microbial Dynamics and Infection, School of Biological Sciences, Georgia Institute of Technology